Showing results (911-920 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|August 21, 2019
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors responseMaria A Pantaleo, Giuseppe Tarantino, Claudio Agostinelli, et al.
Oncoimmunology|August 21, 2019
T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppressionAlexandra Kegler, Stefanie Koristka, Ralf Bergmann, et al.
Oncoimmunology|August 21, 2019
Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor CytotoxicityRonit Vogt Sionov, Tanya Fainsod-Levi, Tamir Zelter, et al.
Oncoimmunology|August 21, 2019
HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memoryChristian Grunwitz, Nadja Salomon, Fulvia Vascotto, et al.
Oncoimmunology|January 25, 2021
Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastomaSoheila Shirinbak, Randall Y Chan, Shilpa Shahani, et al.
Oncoimmunology|January 25, 2021
Prognostic role of stromal tumor-infiltrating lymphocytes in locally advanced upper tract urothelial carcinoma: A retrospective multicenter study (TSU-02 study)Sida Cheng, Wenlong Zhong, Kun Xia, et al.
Oncoimmunology|January 25, 2021
Single-cell transcriptome analysis of CAR T-cell products reveals subpopulations, stimulation, and exhaustion signaturesXiaonan Wang, Carlotta Peticone, Ekaterini Kotsopoulou, et al.
Oncoimmunology|February 1, 2021
A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
Oncoimmunology|February 1, 2021
NFATc3 inhibits hepatocarcinogenesis and HBV replication via positively regulating RIG-I-mediated interferon transcriptionXiaobin Zao, Jin Cheng, Congle Shen, et al.
Oncoimmunology|January 18, 2021
Targeted Stat2 deletion in conventional dendritic cells impairs CTL responses but does not affect antibody productionConnie C Qiu, Kevin P Kotredes, Tess Cremers, et al.
Pageof 379